Risk factors for infections requiring hospitalization in renal transplant recipients: a cohort study

被引:18
|
作者
Valdez-Ortiz, Rafael [1 ]
Sifuentes-Osornio, Jose [2 ]
Morales-Buenrostro, Luis E. [1 ]
Ayala-Palma, Harold [1 ]
Dehesa-Lopez, Edgar [1 ]
Alberu, Josefina [3 ]
Correa-Rotter, Ricardo [1 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Nephrol & Mineral Metab, Mexico City 14000, DF, Mexico
[2] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Lab Clin Microbiol, Mexico City 14000, DF, Mexico
[3] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Transplantat, Mexico City 14000, DF, Mexico
关键词
Infection; Renal transplantation; Risk factors; CHRONIC KIDNEY-DISEASE; URINARY-TRACT-INFECTIONS; CYTOMEGALOVIRUS-INFECTION; ALLOGRAFT RECIPIENTS; PREEMPTIVE THERAPY; VIRAL-INFECTION; EPIDEMIOLOGY; IMPACT; COMPLICATIONS; GUIDELINES;
D O I
10.1016/j.ijid.2010.11.004
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Our aim was to analyze a retrospective cohort of renal transplant recipients to determine the risk factors for infections that require hospitalization. Methods: This was a cohort study that included patients who had received kidney transplants from January 1990 to December 2003. The statistical analysis was performed according to the distribution of variables, and p < 0.05 was considered statistically significant. Results: We analyzed 366 transplants in 350 patients, of whom 161 (46%) presented with an episode of infection requiring hospitalization. These 161 patients developed 323 infections (a median of two infections per patient). The incidence rate was 0.46 episodes per 1000 transplant-days. Urinary tract infection, pneumonia, bacteremia, and gastroenteritis were the most common diseases. A high incidence of infections due to Escherichia coli and Enterococcus species, as well as Candida species, was found. By multivariate Cox model, significant risk factors for infections requiring hospitalization were systemic lupus erythematosus (relative risk (RR) 4.8, 95% confidence interval (CI) 1.64-14.1), cancer (RR 3.81, 95% CI 1.05-13.7), previous renal transplant (RR 5.6, 95% CI 1.4-22.4), history of anti-rejection therapy (RR 3.2, 95% CI 1.3-8.0), and a basal serum albumin concentration < 3.5 mg/dl (RR 1.77, 95% CI 1.17-2.68). Interestingly, dyslipidemia (RR 0.5, 95% CI 0.37-0.69) and end-stage renal disease of unknown etiology (RR 0.5, 95% CI 0.3-0.8) were protective factors against hospitalization. Conclusions: These data suggest that the most common infections requiring hospitalization in our cohort were those caused by microorganisms commonly related with community-acquired infections rather than those classically associated with immunosuppressant therapy. These findings will be useful for refining medical care. (C) 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:E188 / E196
页数:9
相关论文
共 50 条
  • [21] STUDY OF UNUSUAL/RARE INFECTIONS IN RENAL TRANSPLANT RECIPIENTS
    Chilaka, Rajesh
    Mishra, Utkarsh
    Jayaprakash, T.
    Jain, Ankit
    Alam, Rizwan
    Johny, Joseph
    Jose, Nisha
    Mani, Selvin Sundar Raj
    Yusuf, Sabina
    Eapen, Jeethu Joseph
    Thomas, Athul
    John, Elenjickal Elias
    Alexander, Suceena
    David, Vinoi George
    Michael, Joy Sarojini
    Balaji, V.
    Mammen, Shoba
    Varughese, Santosh
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I962 - I962
  • [22] Risk factors for cardiovascular disease in renal transplant recipients
    Marcucci, R
    Brunelli, T
    Salvadori, M
    Zanazzi, M
    Bertone, E
    Rogolino, A
    Fedi, S
    Prisco, D
    Abbate, R
    Gensini, GF
    THROMBOSIS RESEARCH, 1998, 91 (03) : S120 - S121
  • [23] Risk factors for malignancy in Japanese renal transplant recipients
    Imao, Tetsuya
    Ichimaru, Naotsugu
    Takahara, Shiro
    Kokado, Yukito
    Okumi, Masayoshi
    Imamura, Ryoichi
    Namba, Yukiomi
    Isaka, Yoshitaka
    Nonomura, Norio
    Okuyama, Akihiko
    CANCER, 2007, 109 (10) : 2109 - 2115
  • [24] Risk of nonpulmonary infections requiring hospitalization in spondyloarthritis
    Chung, Ho Yin
    Chan, Shirley Chiu Wai
    Sun, Frances Sze Kei
    IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (05)
  • [25] Risk factors and outcome of stroke in renal transplant recipients
    Findlay, Mark D.
    Thomson, Peter C.
    MacIsaac, Rachael
    Jardine, Alan G.
    Patel, Rajan K.
    Stevens, Kathryn K.
    Rutherford, Elaine
    Clancy, Marc
    Geddes, Colin C.
    Dawson, Jesse
    Mark, Patrick B.
    CLINICAL TRANSPLANTATION, 2016, 30 (08) : 918 - 924
  • [26] Risk factors and prognosis for proteinuria in renal transplant recipients
    Sancho, A.
    Gavela, E.
    Avila, A.
    Morales, A.
    Fernandez-Najera, J. E.
    Crespo, J. F.
    Pallardo, L. M.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2145 - 2147
  • [27] Cardiovascular risk factors and their management in renal transplant recipients
    He, Xiang
    MacPhee, Iain
    Johnston, Atholl
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 (06) : 998 - 999
  • [28] Leukopenia in renal transplant recipients, risk factors and complications
    Khan, Ali R.
    Patel, Anita
    AlHakeem, Moushen
    Goggins, Mariella
    Parasuraman, Ravi
    Karthikeyan, Vanji
    Venkat, K. K.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (04) : A53 - A53
  • [29] Risk factors for osteoporosis in young renal transplant recipients
    Sezer, S
    Ozdemir, FN
    Ibis, A
    Sayin, B
    Haberal, M
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (07) : 3116 - 3118
  • [30] CARDIOVASCULAR RISK FACTORS IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS
    Kadioglu, Banu
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1644 - 1644